CLINICAL_TRIALS
trial_result
· 2021-05-26
Clinical Trial Update: DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001
Summary
Retrospective study update of DEXYCU 9% intraocular suspension in cataract patients; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EyePoint Pharmaceuticals, Inc. | Conditions: Cataract | Status: COMPLETED | Results posted: 2021-05-26